Pharmacokinetics (PK) is the study of what the body does to a drug during a clinical study and refers to the time course of absorption, bioavailability, distribution, metabolism and excretion of the drug.
Pharmacodynamics (PD) is the study of the biochemical, physiological and molecular effects of a therapeutic on the body. PD assessments provide vital information on the receptor binding, pathways, genes, RNA and proteins.
Biomarkers are playing an increasingly important role in clinical studies where they can provide essential efficacy, safety, and pathology data around the drug and indication being investigated.
Agilex Biolabs offers a range of toxicology services to support non-clinical through to early/late-phase clinical programs through our state-of-the-art, custom-built GLP facility located in Brisbane, Australia.
Occumqui dolorenis pe dolorpore volupit omnimol uptius ipsuntiaeris imolut evellor ianducia iliquosseque verias voluptusdae voluta in consento ex et experum, qui rae veni sande veresec tinctectur.
Occumqui dolorenis pe dolorpore volupit omnimol uptius ipsuntiaeris imolut evellor ianducia iliquosseque verias voluptusdae voluta in consento ex et experum, qui rae veni sande veresec tinctectur.